CoChat

The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.

Bipolar depression: a major unsolved challenge

Open access
Baldessarini, Ross J., Vázquez, Gustavo H., Tondo, Leonardo · 2020 · International Journal of Bipolar Disorders

Abstract

Depression in bipolar disorder (BD) patients presents major clinical challenges. As the predominant psychopathology even in treated BD, depression is associated not only with excess morbidity, but also mortality from co-occurring general-medical disorders and high suicide risk. In BD, risks for medical disorders including diabetes or metabolic syndrome, and cardiovascular disorders, and associated mortality rates are several-times above those for the general population or with other psychiatric disorders. The SMR for suicide with BD reaches 20-times above general-population rates, and exceeds rates with other major psychiatric disorders. In BD, suicide is strongly associated with mixed (agitated-dysphoric) and depressive phases, time depressed, and hospitalization. Lithium may reduce suicide risk in BD; clozapine and ketamine require further testing. Treatment of bipolar depression is far less well investigated than unipolar depression, particularly for long-term prophylaxis. Short-term efficacy of antidepressants for bipolar depression remains controversial and they risk clinical worsening, especially in mixed states and with rapid-cycling. Evidence of efficacy of lithium and anticonvulsants for bipolar depression is very limited; lamotrigine has long-term benefit, but valproate and carbamazepine are inadequately tested and carry high teratogenic risks. Evidence is emerging of short-term efficacy of several modern antipsychotics (including cariprazine, lurasidone, olanzapine-fluoxetine, and quetiapine) for bipolar depression, including with mixed features, though they risk adverse metabolic and neurological effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40345-019-0160-1

Cites

189 of 189 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 189 references

Research works printed but not linked: 5

  1. Fountoulakis KN, Vieta E, Young A, et al. Unmet needs in the treatment of bipolar disorder and recommendations for future research. Int J Neuropsychopharmacol. 2017;20(2):196–205.
  2. Laughren TP. Proceedings of a meeting of the Psychopharmacology Drug Advisory Committee (PDAC) concerning suicidal risk in trials of antidepressant drugs in juvenile and adult patients, 2006. http://www.fda.gov/ohrms/dockets/ac/06/briefing//2006-4272b1-01-fda.pdf. Accessed 22 Dec 2018.
  3. Müller-Oerlinghausen B, Ahrens B, Felber W. Suicide-preventive and mortality-reducing effect of lithium. In: Bauer M, Grof P, Müller-Oerlinghausen B, editors. Lithium in neuropsychiatry. London: Informa Healthcare; 2006. p. 79–192.
  4. Simon RI, Hales RE, editors. Textbook of suicide assessment and management. 2nd ed. Washington, DC: American Psychiatric Press; 2012.
  5. Vázquez GH, Forte A, Camino S, Tondo L, Baldessarini RJ. Chapt 17: Psychiatric comorbidity in bipolar disorder: treatment implications: anxiety syndromes and substance abuse. In: Carvalho E, Vieta E, editors. The treatment of bipolar disorder: integrative treatment strategies and future directions. New York: Oxford University Press; 2017b. p. 225–54.

Cited by

See all 235

Metadata

Authors
Baldessarini, R. J., Vázquez, G. H., & Tondo, L.
Affiliations
  • Harvard University (US)
  • Queen's University (CA)
Corresponding author
Baldessarini, Ross J.
Venue
International Journal of Bipolar Disorders
Published
2020-01-06
Volume
8
Issue
1
Pages
1-1
ISSN
2194-7511 (ISSN-L)
OpenAlex
W3000431195
Cited by
235
References
189
Citations by year
2026: 29 · 2025: 36 · 2024: 36 · 2023: 42 · 2022: 38 · 2021: 33 · 2020: 20
FWCI
5.50
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Bipolar Disorders (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Bruce J Anderson Foundation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords
bipolar depression, bipolar disorder, suicide risk, mixed states, rapid cycling, antidepressant-induced mania, lithium, lamotrigine, antiepileptic drugs, antipsychotic drugs, cariprazine, lurasidone, quetiapine, teratogenicity, valproic acid, carbamazepine, mortality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bipolar depression: a major unsolved challenge. https://app.cochat.ai/papers/10.1186/s40345-019-0160-1
The paper
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020). Bipolar depression: a major unsolved challenge. International Journal of Bipolar Disorders. https://doi.org/10.1186/s40345-019-0160-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.